What is NAGE's P/E ratio?

NIAGEN BIOSCIENCE, INC. (NAGE) currently trades at a P/E ratio of 14.19.

NIAGEN BIOSCIENCE, INC. reports a Return on Equity (ROE) of 22.64%.

What is NAGE's dividend yield?

NIAGEN BIOSCIENCE, INC. offers a dividend yield of 0.00%.

What is NAGE's Quality Score?

Our AI rates NAGE's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy NAGE?

Our AI Timing Score for NAGE is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does NAGE belong to?

NIAGEN BIOSCIENCE, INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

NAGE (NASDAQ) Stock Analysis | NIAGEN BIOSCIENCE, INC.

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

NAGE AI Analysis Summary

Our AI summary for NAGE: NIAGEN BIOSCIENCE, INC. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 14.19, ROE of 22.64%, a dividend yield of 0.00%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

NAGE

NIAGEN BIOSCIENCE, INC.

US:NASDAQ STOCK Healthcare >> Biotechnology News 99

USD 3.40

0.08 (2.41%) Day Change

Watchlist Portfolio Compare Chart

14.19

P/E

0.01

D/E

22.6%

ROE

16.3%

ROA

0.00%

Div Yield

-0.17

PEG

NIAGEN BIOSCIENCE, INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 3.40 Price 0.08 (2.41%) Day Change	NEWS SCORE: 99

NAGE, the overall quality is ok ( Quality = 62) and the timing to buy is ...(Sign In to See)...

Loading chart...

62 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

50%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	382
Magic Formula Rank by ROE	382
Magic Formula Rank by ROIC	299
Price	3.40
PBV / Sector	3.21 / 5.20
Earning Per Share	0.24

PE / Sector	14.19 / 19.97
PEG or PE/Growth / Sector	-0.17 / 1.22
Average 1M Daily Value	2.35 M GREAT
Average 1W Daily Value	1.95 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	14.29 / 98.71
NPM Average (%) / Sector	1.49 / -1,721.76
NPM Change Average (%) / Sector	-64.17 / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	16.30 / 27.02 GOOD
ROA Average (%) / Sector	1.12 / -368.17
ROA Change Average (%) / Sector	-69.95 / 5,404.12
ROE (%) / Sector	22.64 / 3.47 GOOD
ROE Average (%) / Sector	-2.23 / 6.51
ROE Change Average (%) / Sector	-63.67 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 08:00:12
Symbol	NAGE
Name	NIAGEN BIOSCIENCE, INC.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	79.64 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	264.42 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 10900 Wilshire Blvd, Los Angeles, CA, United States, 90024

Phone: 310 388 6706

Website: https://www.niagenbioscience.com

Employees: 117

Sector: Healthcare >> Biotechnology

Description: Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and authorized healthcare practitioners resellers. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.